Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sinovac Biotech Ltd.    SVA   AGP8696W1045

SINOVAC BIOTECH LTD.

(SVA)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Financials (USD)
Sales 2018 230 M - -
Net income 2018 21,8 M - -
Net cash position 2018 163 M - -
P/E ratio 2018 20,6x
Yield 2018 -
Sales 2019 246 M - -
Net income 2019 44,9 M - -
Net cash position 2019 183 M - -
P/E ratio 2019 17,8x
Yield 2019 -
Capitalization 640 M 640 M -
EV / Sales 2018 1,38x
EV / Sales 2019 1,86x
Nbr of Employees 910
Free-Float 34,7%
More Financials
Company
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
All news about SINOVAC BIOTECH LTD.
03:24aSINOVAC BIOTECH : Indonesia reports record daily increase in COVID-19 cases
RE
01/15SINOVAC BIOTECH : Brazil airlifts emergency oxygen into pandemic-struck state, v..
RE
01/14WRAPUP 1-China steals march on West in developing nations' vaccine rollout
RE
01/14Philippines approves Pfizer-BioNTech vaccine for emergency use
RE
01/13SINOVAC BIOTECH : Philippines approves Pfizer-BioNTech vaccine for emergency use
RE
01/13Brazil to start COVID-19 vaccination with shots imported from China and India
RE
01/13SINOVAC BIOTECH : Ukraine pharma group to supply 5 million doses of Sinovac COVI..
RE
01/13SINOVAC BIOTECH : China's Sinovac to double annual COVID-19 vaccine capacity to ..
RE
01/12SINOVAC BIOTECH : Indonesia president says vaccine will help stop virus spread, ..
RE
01/12Indonesia launches one of world's biggest COVID-19 vaccination drives
RE
01/12Indonesia to launch vaccination drive as COVID-19 deaths hit record
RE
01/12Malaysia's Pharmaniaga buys 14 million doses of China's Sinovac COVID vaccine
RE
01/11SINOVAC BIOTECH : vaccine efficacy less than 60% in Brazil trial -report
RE
01/11Malaysia imposes 2-week lockdown as virus spread strains hospitals
RE
01/11Philippines books 25 million doses of Sinovac's COVID-19 vaccine
RE
More news
News in other languages on SINOVAC BIOTECH LTD.
01/13SINOVAC BIOTECH : Studiendaten aus Brasilien schüren Zweifel an Sinovac-Impfstof..
01/11WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
2020Coronavirus-La Chine travaille à une usine de vaccins à ARN
2020SINOVAC BIOTECH : Coronavirus-La Chine vaccinera les "populations clés" cet hive..
2020CORONAVIRUS : Sinovac Biotech obtient un financement de 515 millions de dollars ..
More news
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang Chief Financial Officer & Vice President
Qiang Gao Vice President-Research & Development
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SINOVAC BIOTECH LTD.-6.77%640
CSL LIMITED-5.62%93 853
SAMSUNG BIOLOGICS CO.,LTD.-2.66%48 243
BIOGEN INC.12.65%42 447
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.-2.71%35 533
ALEXION PHARMACEUTICALS, INC.0.26%34 293